A detailed history of Cetera Investment Advisers transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 14,885 shares of RCKT stock, worth $261,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,885
Previous 12,746 16.78%
Holding current value
$261,678
Previous $343,000 6.71%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 22, 2024

BUY
$20.66 - $26.72 $44,191 - $57,154
2,139 Added 16.78%
14,885 $320,000
Q1 2024

May 24, 2024

BUY
$26.16 - $30.74 $333,435 - $391,812
12,746 New
12,746 $343,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.33B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.